About Complement factor D
Complement factor D (CFD) is a protein
from Homo sapiens identified by UniProt accession
P00746, 253 residues long.
MolForge cross-references it against 0 known binders and
287 disease associations.
Target properties
| Protein name | Complement factor D |
| UniProt accession | P00746 |
| Gene | CFD |
| Organism | Homo sapiens |
| Length | 253 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (287)
Diseases linked to this target (Open Targets).
- recurrent Neisseria infections due to factor D deficiency · score 0.73
- atrophic macular degeneration · score 0.36
- paroxysmal nocturnal hemoglobinuria · score 0.34
- reticulocyte count · score 0.33
- neurodegenerative disease · score 0.32
- monocyte percentage of leukocytes · score 0.28
- Immature Reticulocyte Fraction Measurement · score 0.21
- complement component C8 measurement · score 0.18
- reticulocyte measurement · score 0.15
- neurofibrillary tangles measurement · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P00746-F1 | alphafold | PREDICTED | 90.99 | — |
Amino-acid sequence (253 residues)
MHSWERLAVL VLLGAAACAA PPRGRILGGR EAEAHARPYM ASVQLNGAHL CGGVLVAEQW VLSAAHCLED AADGKVQVLL GAHSLSQPEP SKRLYDVLRA VPHPDSQPDT IDHDLLLLQL SEKATLGPAV RPLPWQRVDR DVAPGTLCDV AGWGIVNHAG RRPDSLQHVL LPVLDRATCN RRTHHDGAIT ERLMCAESNR RDSCKGDSGG PLVCGGVLEG VVTSGSRVCG NRKKPGIYTR VASYAAWIDS VLA
Explore Complement factor D with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets